Revised European American classification. 13 
monocytic subtypes. 18, 19 Approximately 30% of EMCT at pressarcoma entation have normal peripheral blood counts with no leukemic blasts, normal bone marrow examination and no history of preceding leukemia (primary EMCT). 18 The most Monocytes and macrophages are part of the body defense syscommon sites for these primary EMCT are skin, lymph nodes, tem and are considered 'professional phagocytes'. 1 Their dissoft tissues and small intestine. 19 These sites are rather identtinctive phagocytic capability together with the absence of ical to those of THL. 4 In fact, AMoL have been described as ultrastructural bodies, known as Birbeck granules, differentiate having a lymphoma-like presentation. 20 New cases of myeloid them from the other members of the histiocytic group, namely leukemia in the USA are estimated at 12 800 for 1996 while Langerhans cells and dendritic cells. 1 Monocytes arise in the those for NHL are estimated to be 52 700. 21 From the prebone marrow from a stem cell designated colony-forming unit viously mentioned incidences, if myeloid leukemias granulocyte-macrophage (CFU-GM). Monocytes briefly circupresenting as EMCT represents 1.5%, this would result in late in the blood before entering the tissues to become macroapproximately 190 cases per year, the majority of which repphages. 1 Therefore, both monocytes and macrophages are resent monocytic leukemias. For THL, if the incidence is 0.3% closely related in origin, structure and function.
of all NHL, this would result in approximately 160 cases per True histiocytic lymphoma (THL) or histiocytic sarcoma is year which is rather similar to the incidence of primary EMCT. an uncommon type of non-Hodgkin's lymphoma (NHL) com-
The question now becomes if a patient presents with an posed of neoplastic phagocytic histiocytes. 2 THL usually extramedullary tumor of monocyte/macrophage lineage at presents as localized tumors which may or may not progress these sites, is it feasible to differentiate between THL and to disseminated disease. 3 The prefix 'true' was added to help extramedullary presentation of acute monocytic leukemia or differentiate this entity from 'histiocytic lymphoma', a term do we need to? Are there markers to help differentiate used in the Rappaport classification to describe large cell lymbetween a neoplastic monocyte and a neoplastic macrophoma of lymphoid origin. 4 With the introduction of better phage? techniques for studying the lineage of different cell types, immunophenotyping of hematologic neoplasms on fixed Morphologic difference paraffin-embedded tissue has become a fairly reliable method which correlates well with genotypic analysis. 5 These new The morphology of THL is highly variable. It varies from rather methods of phenotyping and genotyping has brought to queshomogeneous cells with a large amount of cytoplasm and tion the existence of histiocytic neoplasia in general and THL indented nuclei to pleomorphic, bizarre shapes with multinuin particular. 6, 7 THL is becoming more rare when retrospective cleation. 4 However, even in recent reports, some cases of studies are performed on archival material using these new anti-CD30-positive anaplastic large cell lymphoma are included bodies. A high percentage of histiocytic neoplasms are reclassiwith THL. 
